Parvina Rahmonova, the fifth daughter of authoritarian Tajik President Emomali Rahmon, has a virtually nonexistent public footprint. But thanks in part to millions in government contracts, a pharmaceutical company she owns has become a dominant force in the country’s health-care sector.